A phase I study of the combination of sorafenib (Sor) and bortezomib (Bor) in patients (pts) with metastatic melanoma (MM)

被引：0
|
作者：
Sullivan, Ryan J.
Ibrahim, Nageatte
Lawrence, Donald P.
Aldridge, Julie
Hodi, F. Stephen
Flaherty, Keith
Conley, Christine
DeNoble, Sarah
Mier, James Walter
Cho, Daniel C.
Atkins, Michael B.
McDermott, David F.
机构：
[1] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
[3] Dana Farber Canc Inst, Int Beast Canc Study Grp Stat Ctr, Boston, MA 02115 USA
[4] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Canc, Boston, MA USA
[5] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[6] Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9076
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Phase I/II study of E7050 (golvantinib) in combination with sorafenib in patients (pts) with advanced hepatocellular carcinoma (HCC): Phase I results
    O'Neil, Bert H.
    Bendell, Johanna C.
    Modiano, Manuel R.
    Machiels, Jean-Pascal H.
    Versola, Melissa Jo
    Hodge, Jeff Paul
    Sawarna, Karen
    Tse, Nielson
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [42] Phase I/II study of imexon (AMP) plus dacarbazine (DTIC) in patients (Pts) with metastatic malignant melanoma
    Samlowski, W. E.
    Weber, J. S.
    Gonzalez, R.
    Ribas, A.
    O'Day, S. J.
    Stephenson, J. J.
    Sato, T.
    Dorr, R. T.
    Grenier, K. A.
    Hersh, E. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [43] Phase I/II study of LOC-paclitaxel (LOC-Pac) in patients (pts) with metastatic melanoma
    Bedikian, Agop Y.
    Kim, Kevin B.
    Papadopoulos, Nicholas E.
    Hwu, Wen-Jen
    Patel, Sapna Pradyuman
    Davies, Michael A.
    Mahoney, Sandy
    Hwu, Patrick
    Woodman, Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [44] A phase I study of vorinostat in combination with bortezomib in patients with advanced malignancies
    Schelman, William R.
    Traynor, Anne M.
    Holen, Kyle D.
    Kolesar, Jill M.
    Attia, Steven
    Hoang, Tien
    Eickhoff, Jens
    Jiang, Zhisheng
    Alberti, Dona
    Marnocha, Rebecca
    Reid, Joel M.
    Ames, Matthew M.
    McGovern, Renee M.
    Espinoza-Delgado, Igor
    Wright, John J.
    Wilding, George
    Bailey, Howard H.
    INVESTIGATIONAL NEW DRUGS, 2013, 31 (06) : 1539 - 1546
  • [45] A phase I study of vorinostat in combination with bortezomib in patients with advanced malignancies
    William R. Schelman
    Anne M. Traynor
    Kyle D. Holen
    Jill M. Kolesar
    Steven Attia
    Tien Hoang
    Jens Eickhoff
    Zhisheng Jiang
    Dona Alberti
    Rebecca Marnocha
    Joel M. Reid
    Matthew M. Ames
    Renee M. McGovern
    Igor Espinoza-Delgado
    John J. Wright
    George Wilding
    Howard H. Bailey
    Investigational New Drugs, 2013, 31 : 1539 - 1546
  • [46] Confocal Microscopy Is Useful for Detection of Bortezomib Related Neuropathy (BOR-PN) in Multiple Myeloma (MM) Patients (PTS)
    Cocito, Federica
    Mangiacavalli, Silvia
    Ricciardelli, Gabriella
    Ferretti, Virginia
    Ceccuzzi, Roberto
    Cazzola, Mario
    Bianchi, Paolo Emilio
    Corso, Alessandro
    BLOOD, 2014, 124 (21)
  • [47] Phase I trial of vorinostat plus bortezomib (bort) in relapsed/refractory multiple myeloma (mm) patients (pts)
    Badros, A. Z.
    Philip, S.
    Niesvizk, R.
    Goloubeva, O.
    Harris, C.
    Zweibel, J.
    Wright, J. J.
    Burger, A.
    Baer, M. R.
    Egorin, M. J.
    Grant, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [48] PHASE I TRIAL OF VORINOSTAT PLUS BORTEZOMIB (BORT) IN RELAPSED AND REFRACTORY MULTIPLE MYELOMA (MM) PATIENTS (PTS)
    Badros, Z.
    Philip, S.
    Niesvizky, R.
    Goloubeva, O.
    Harris, C.
    Zweibel, J.
    Wright, J.
    Burger, A.
    Baer, M.
    Egorin, M.
    Grant, S.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 258 - 258
  • [49] A phase II study of bortezomib in the treatment of metastatic malignant melanoma
    Markovic, SN
    Geyer, SM
    Dawkins, F
    Sharfman, W
    Albertini, M
    Maples, W
    Fracasso, PM
    Fitch, T
    LoRusso, P
    Adjei, AA
    Erlichman, C
    CANCER, 2005, 103 (12) : 2584 - 2589
  • [50] Phase I dose escalation study of pomalidomide in combination with gemcitabine in patients (pts) with untreated metastatic carcinoma of the pancreas
    Infante, J. R.
    Jones, S. F.
    Bendell, J.
    Spigel, D.
    Barton, J.
    Zubkus, J.
    Byrne, C.
    Griner, P.
    Weekes, C.
    Messersmith, W. A.
    Burris, H. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345